TTUHSC researcher receives patent for schistosomiasis vaccine - Lubbock AJ
Lubbock AJ - Dr. Afzal Siddiqui received patent for a vaccine he created through TTUHSC research to treat schistosomiasis.
The disease is more prevalent in countries outside the continental United States, potentially putting 800 million people at risk.
“This vaccine is a chance to improve the lives of 200 million people,” said Dr. Michael Conn, vice president of research for TTUHSC, in reference to the number of people affected by the disease. “This kind of opportunity doesn’t come along often.”
Related Stories
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Recent Stories
Texas Tech University Health Sciences Center Earns SACSCOC Recognition
TTUHSC has received a clean bill of health from the regional accrediting body, the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC), following a Fifth-Year Interim Review by a committee from peer institutions.
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
TTUHSC Amarillo Awarded $50,000 Grant for Cutting-Edge Cancer Research
TTUHSC in Amarillo has received a $50,000 grant from the Harrington Cancer and Health Foundation to support groundbreaking cancer research led by Hiranmoy Das, Ph.D.